{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:56:15Z","timestamp":1775487375920,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":301,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Reports"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.ebr.2024.100725","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T07:44:45Z","timestamp":1730274285000},"page":"100725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Should neurologists treat common psychiatric comorbidities in patients with epilepsy?"],"prefix":"10.1016","volume":"28","author":[{"given":"Andres M.","family":"Kanner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi M.","family":"Munger Clary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebr.2024.100725_b0005","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/j.1528-1167.2007.01222.x","article-title":"Psychiatric comorbidity in epilepsy: a population-based analysis","volume":"48","author":"Tellez-Zenteno","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2024.100725_b0010","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0140-6736(13)60899-5","article-title":"Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study","volume":"382","author":"Fazel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ebr.2024.100725_b0015","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.eplepsyres.2007.06.003","article-title":"Predictors of pharmacoresistant epilepsy","volume":"75","author":"Hitiris","year":"2007","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ebr.2024.100725_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107703","article-title":"How frequently is anxiety and depression identified and treated in hospital and community samples of adults with epilepsy?","volume":"115","author":"Scott","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebr.2024.100725_b0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/epi4.12455","article-title":"Managing depression and anxiety in people with epilepsy: a survey of epilepsy health professionals by the ILAE Psychology Task Force","volume":"6","author":"Gandy","year":"2021","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.ebr.2024.100725_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107543","article-title":"Neurologist prescribing versus psychiatry referral: examining patient preferences for anxiety and depression management in a symptomatic epilepsy clinic sample","volume":"114","author":"Munger Clary","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebr.2024.100725_b0035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.eplepsyres.2016.08.017","article-title":"Behavioral health referrals in pediatric epilepsy","volume":"127","author":"Wagner","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ebr.2024.100725_b0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/epd2.20224","article-title":"Anticipatory anxiety of seizures in epilepsy: A common, complex, and underrecognized phenomenon?","volume":"26","author":"Kanner","year":"2024","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.ebr.2024.100725_b0045","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1212\/01.WNL.0000113763.11862.26","article-title":"Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy","volume":"62","author":"Kanner","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ebr.2024.100725_b0050","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.23601","article-title":"Epilepsy, suicidality, and psychiatric disorders: a bidirectional association","volume":"72","author":"Hesdorffer","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebr.2024.100725_b0055","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1212\/CPJ.0000000000000874","article-title":"Psychiatric comorbidities in people with epilepsy","volume":"11","author":"Mula","year":"2021","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.ebr.2024.100725_b0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","article-title":"Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports","volume":"62","author":"Alper","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ebr.2024.100725_b0065","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/epi.14640","article-title":"Medication treatment for attention-deficit\/hyperactivity disorder and the risk of acute seizures in individuals with epilepsy","volume":"60","author":"Brikell","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2024.100725_b0070","doi-asserted-by":"crossref","first-page":"e1104","DOI":"10.1212\/WNL.0000000000005213","article-title":"Attention-deficit\/hyperactivity disorder medication and seizures","volume":"90","author":"Wiggs","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ebr.2024.100725_b0075","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00005053-198608000-00005","article-title":"Mood change preceding epileptic seizures","volume":"174","author":"Blanchet","year":"1986","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.ebr.2024.100725_b0080","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/epi.17215","article-title":"Anticipatory anxiety of seizures is associated with ictal emotional distress and amygdala onset seizures","volume":"63","author":"Tarrada","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2024.100725_b0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1176\/ajp.115.2.97","article-title":"Ictal affect","volume":"115","author":"Daly","year":"1958","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ebr.2024.100725_b0090","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1474-4422(07)70175-8","article-title":"Epilepsy and risk of suicide: a population-based case-control study","volume":"6","author":"Christensen","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebr.2024.100725_b0095","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1528-1167.2008.01938.x","article-title":"Association of subjective anxiety, depression, and sleep disturbance with quality-of-life ratings in adults with epilepsy","volume":"50","author":"Kwan","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2024.100725_b0100","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/epi.12672","article-title":"Seizure frequency and patient-centered outcome assessment in epilepsy","volume":"55","author":"Choi","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2024.100725_b0105","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1212\/WNL.58.8_suppl_5.S9","article-title":"Optimizing health outcomes in active epilepsy","volume":"58","author":"Gilliam","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ebr.2024.100725_b0110","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.yebeh.2003.07.009","article-title":"The influence of comorbid depression on quality of life for people with epilepsy","volume":"4","author":"Cramer","year":"2003","journal-title":"Epilepsy Behav"},{"issue":"5","key":"10.1016\/j.ebr.2024.100725_b0115","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1528-1167.2008.01799.x","article-title":"The role of titration schedule of topiramate for the development of depression in patients with epilepsy","volume":"50","author":"Mula","year":"2009","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.ebr.2024.100725_b0120","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1542\/peds.85.6.1086","article-title":"Phenobarbital treatment and major depressive disorder in children with epilepsy: a naturalistic follow-up","volume":"85","author":"Brent","year":"1990","journal-title":"Pediatrics"},{"key":"10.1016\/j.ebr.2024.100725_b0125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jamaneurol.2018.4561","article-title":"Prediction tools for psychiatric adverse effects after levetiracetam prescription","volume":"76","author":"Josephson","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ebr.2024.100725_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108380","article-title":"Does a psychiatric history play a role in the development of psychiatric adverse events to perampanel... and to placebo?","volume":"125","author":"Kanner","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebr.2024.100725_b0135","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2015.243","article-title":"Management of psychiatric and neurological comorbidities in epilepsy","volume":"12","author":"Kanner","year":"2016","journal-title":"Nat Rev Neurol"}],"container-title":["Epilepsy & Behavior Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986424000820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986424000820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T13:25:40Z","timestamp":1752585940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589986424000820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":27,"alternative-id":["S2589986424000820"],"URL":"https:\/\/doi.org\/10.1016\/j.ebr.2024.100725","relation":{},"ISSN":["2589-9864"],"issn-type":[{"value":"2589-9864","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should neurologists treat common psychiatric comorbidities in patients with epilepsy?","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebr.2024.100725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100725"}}